documents: FDA-2007-D-0369-0294

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0294 FDA FDA-2007-D-0369 Tab 1 FDA Draft Guidance on Naltrexone re Comment from Alkermes Inc Supporting & Related Material Background Material 2014-06-20T04:00:00Z 2014 6     2014-11-04T16:45:18Z   0 0 09000064817355c1

Links from other tables